The use of a single 1.5-mg dose of levonorgestrel instead of two 0.75-mg doses given 12 hours apart is a viable alternative method of emergency contraception.
The use of oral contraceptives in women with BRCA1/2 mutations was associated with a reduced risk of ovarian cancer.
Discontinuation rates at 6 months among users of long-acting reversible contraceptive methods are low and not increased among adolescents and young women.
Women who took oral contraceptives for at least 3 years were twice as likely to have glaucoma, new research shows. The causative effect, however, is unknown.
Medroxyprogesterone acetate (MPA) and tranexamic acid effectively treat heavy menstrual bleeding, but more adverse effects and less patient satisfaction are reported with MPA use.
Abuse inflicted during childhood is lasting. Remember that adult patients may be survivors of child abuse, which makes them at risk for being in abusive relationships and for abusing their own children.
Misoprostol for cervical ripening prior to insertion of an IUD in nulliparous women not only did not improve ease of insertion for the provider but resulted in increased procedure-related pain.
The duty to nonmaleficence suggests that it might be most ethical to deny patients when what they want presents too much risk, and too little benefit--even at the expense of respecting their autonomy.
The increased availability of emergency contraception to women and girls irrespective of age is victory for all of us.
There is insufficient evidence to determine that hormonal contraceptives do not influence glucose and lipid metabolism in women with diabetes mellitus, concluded a systematic review conducted by the Cochrane Fertility Regulation Group.